Advancements in kidney organoids and tubuloids to study (dys)function

E Dilmen1, I Orhon1, J Jansen2

  • 1Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Trends in Cell Biology
|October 21, 2023
PubMed

Insights

Novel kidney organoids and tubuloids offer advanced in vitro models for studying kidney disease and drug effects. These functional models show promise for personalized medicine and developing new kidney therapies.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Biotechnology

Background:

  • Kidney diseases are increasing, necessitating new therapeutic strategies.
  • Kidney organoids and tubuloids are sophisticated in vitro models that mimic kidney (patho)physiology.
  • These models are emerging as valuable tools for disease modeling, drug screening, and assessing nephrotoxicity.

Purpose of the Study:

  • To review recent advancements in functional kidney organoid and tubuloid models.
  • To highlight their applications in mimicking kidney (dys)function, including transport and endocrine activity.
  • To discuss current limitations and future perspectives for translational and personalized kidney medicine.

Main Methods:

  • Literature review of recent developments in kidney organoid and tubuloid research.
  • Focus on studies demonstrating functional mimicry of kidney physiology and pathophysiology.
  • Analysis of applications in disease modeling, drug screening, and nephrotoxicity assessment.

Main Results:

  • Kidney organoids and tubuloids can replicate key kidney functions in vitro, such as endocrine activity and transport processes.
  • These models have demonstrated utility in disease modeling and drug testing.
  • Recent developments focus on enhancing the functional complexity and physiological relevance of these models.

Conclusions:

  • Functional kidney organoids and tubuloids represent a significant advancement in in vitro kidney research.
  • Their ability to mimic kidney (dys)function holds great potential for accelerating the development of novel kidney therapies.
  • Further development is crucial for realizing their full potential in translational and personalized medicine.